The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis c virus genotype 1 infection without cirrhosis
Michael P. Manns*, John M. Vierling, Bruce R. Bacon, Savino Bruno, Oren Shibolet, Yaacov Baruch, Patrick Marcellin, Luzelena Caro, Anita Y.M. Howe, Christine Fandozzi, Jacqueline Gress, Christopher L. Gilbert, Peter M. Shaw, Michael P. Cooreman, Michael N. Robertson, Peggy Hwang, Frank J. Dutko, Janice Wahl, Niloufar Mobashery
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis c virus genotype 1 infection without cirrhosis'. Together they form a unique fingerprint.